Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Philip Bradley is active.

Publication


Featured researches published by Philip Bradley.


Methods in Enzymology | 2011

Rosetta3: An Object-Oriented Software Suite for the Simulation and Design of Macromolecules

Andrew Leaver-Fay; Michael D. Tyka; Steven M. Lewis; Oliver F. Lange; James Thompson; Ron Jacak; Kristian W. Kaufman; P. Douglas Renfrew; Colin A. Smith; Will Sheffler; Ian W. Davis; Seth Cooper; Adrien Treuille; Daniel J. Mandell; Florian Richter; Yih-En Andrew Ban; Sarel J. Fleishman; Jacob E. Corn; David E. Kim; Sergey Lyskov; Monica Berrondo; Stuart Mentzer; Zoran Popović; James J. Havranek; John Karanicolas; Rhiju Das; Jens Meiler; Tanja Kortemme; Jeffrey J. Gray; Brian Kuhlman

We have recently completed a full re-architecturing of the ROSETTA molecular modeling program, generalizing and expanding its existing functionality. The new architecture enables the rapid prototyping of novel protocols by providing easy-to-use interfaces to powerful tools for molecular modeling. The source code of this rearchitecturing has been released as ROSETTA3 and is freely available for academic use. At the time of its release, it contained 470,000 lines of code. Counting currently unpublished protocols at the time of this writing, the source includes 1,285,000 lines. Its rapid growth is a testament to its ease of use. This chapter describes the requirements for our new architecture, justifies the design decisions, sketches out central classes, and highlights a few of the common tasks that the new software can perform.


Science | 2012

The Crystal Structure of TAL Effector PthXo1 Bound to Its DNA Target.

Amanda Nga-Sze Mak; Philip Bradley; Raúl Andrés Cernadas; Adam J. Bogdanove; Barry L. Stoddard

Wrapped DNA TAL effectors are proteins that bacterial pathogens inject into plant cells that bind to host DNA to activate expression of plant genes. The DNA-binding domain of TAL proteins is composed of tandem repeats within which a repeat-variable diresidue sequence confers nucleotide specificity. Deng et al. (p. 720, published online 5 January) report the structure of the TAL effector dHax3, containing 11.5 repeats, in DNA-free and DNA-bound states, and Mak et al. (p. 716, published online 5 January) report the structure of the PthXo1 TAL effector, containing 22 repeats, bound to its DNA target. Together, the structures reveal the conformational changes involved in DNA binding and provide the structural basis of DNA recognition. Structures show how a virulence factor in a plant pathogen recognizes and binds to host DNA. DNA recognition by TAL effectors is mediated by tandem repeats, each 33 to 35 residues in length, that specify nucleotides via unique repeat-variable diresidues (RVDs). The crystal structure of PthXo1 bound to its DNA target was determined by high-throughput computational structure prediction and validated by heavy-atom derivatization. Each repeat forms a left-handed, two-helix bundle that presents an RVD-containing loop to the DNA. The repeats self-associate to form a right-handed superhelix wrapped around the DNA major groove. The first RVD residue forms a stabilizing contact with the protein backbone, while the second makes a base-specific contact to the DNA sense strand. Two degenerate amino-terminal repeats also interact with the DNA. Containing several RVDs and noncanonical associations, the structure illustrates the basis of TAL effector–DNA recognition.


Nature | 2007

High-resolution structure prediction and the crystallographic phase problem

Bin Qian; Srivatsan Raman; Rhiju Das; Philip Bradley; Airlie J. McCoy; Randy J. Read; David Baker

The energy-based refinement of low-resolution protein structure models to atomic-level accuracy is a major challenge for computational structural biology. Here we describe a new approach to refining protein structure models that focuses sampling in regions most likely to contain errors while allowing the whole structure to relax in a physically realistic all-atom force field. In applications to models produced using nuclear magnetic resonance data and to comparative models based on distant structural homologues, the method can significantly improve the accuracy of the structures in terms of both the backbone conformations and the placement of core side chains. Furthermore, the resulting models satisfy a particularly stringent test: they provide significantly better solutions to the X-ray crystallographic phase problem in molecular replacement trials. Finally, we show that all-atom refinement can produce de novo protein structure predictions that reach the high accuracy required for molecular replacement without any experimental phase information and in the absence of templates suitable for molecular replacement from the Protein Data Bank. These results suggest that the combination of high-resolution structure prediction with state-of-the-art phasing tools may be unexpectedly powerful in phasing crystallographic data for which molecular replacement is hindered by the absence of sufficiently accurate previous models.


Proteins | 2003

Automated prediction of CASP‐5 structures using the Robetta server

Dylan Chivian; David E. Kim; Lars Malmström; Philip Bradley; Timothy Robertson; Paul Murphy; Charles E.M. Strauss; Richard Bonneau; Carol A. Rohl; David Baker

Robetta is a fully automated protein structure prediction server that uses the Rosetta fragment‐insertion method. It combines template‐based and de novo structure prediction methods in an attempt to produce high quality models that cover every residue of a submitted sequence. The first step in the procedure is the automatic detection of the locations of domains and selection of the appropriate modeling protocol for each domain. For domains matched to a homolog with an experimentally characterized structure by PSI‐BLAST or Pcons2, Robetta uses a new alignment method, called K*Sync, to align the query sequence onto the parent structure. It then models the variable regions by allowing them to explore conformational space with fragments in fashion similar to the de novo protocol, but in the context of the template. When no structural homolog is available, domains are modeled with the Rosetta de novo protocol, which allows the full length of the domain to explore conformational space via fragment‐insertion, producing a large decoy ensemble from which the final models are selected. The Robetta server produced quite reasonable predictions for targets in the recent CASP‐5 and CAFASP‐3 experiments, some of which were at the level of the best human predictions. Proteins 2003;53:524–533.


Proteins | 2007

Structure prediction for CASP7 targets using extensive all-atom refinement with Rosetta@home

Rhiju Das; Bin Qian; Srivatsan Raman; Robert B. Vernon; James Thompson; Philip Bradley; Sagar D. Khare; Michael D. Tyka; Divya Bhat; Dylan Chivian; David E. Kim; William Sheffler; Lars Malmström; Andrew M. Wollacott; Chu Wang; Ingemar André; David Baker

We describe predictions made using the Rosetta structure prediction methodology for both template‐based modeling and free modeling categories in the Seventh Critical Assessment of Techniques for Protein Structure Prediction. For the first time, aggressive sampling and all‐atom refinement could be carried out for the majority of targets, an advance enabled by the Rosetta@home distributed computing network. Template‐based modeling predictions using an iterative refinement algorithm improved over the best existing templates for the majority of proteins with less than 200 residues. Free modeling methods gave near‐atomic accuracy predictions for several targets under 100 residues from all secondary structure classes. These results indicate that refinement with an all‐atom energy function, although computationally expensive, is a powerful method for obtaining accurate structure predictions. Proteins 2007.


Proteins | 2003

Rosetta Predictions in CASP5: Successes, Failures, and Prospects for Complete Automation

Philip Bradley; Dylan Chivian; Jens Meiler; Kira M.S. Misura; Carol A. Rohl; William R. Schief; William J. Wedemeyer; Ora Schueler-Furman; Paul Murphy; Jack Schonbrun; Charles E.M. Strauss; David Baker

We describe predictions of the structures of CASP5 targets using Rosetta. The Rosetta fragment insertion protocol was used to generate models for entire target domains without detectable sequence similarity to a protein of known structure and to build long loop insertions (and N‐and C‐terminal extensions) in cases where a structural template was available. Encouraging results were obtained both for the de novo predictions and for the long loop insertions; we describe here the successes as well as the failures in the context of current efforts to improve the Rosetta method. In particular, de novo predictions failed for large proteins that were incorrectly parsed into domains and for topologically complex (high contact order) proteins with swapping of segments between domains. However, for the remaining targets, at least one of the five submitted models had a long fragment with significant similarity to the native structure. A fully automated version of the CASP5 protocol produced results that were comparable to the human‐assisted predictions for most of the targets, suggesting that automated genomic‐scale, de novo protein structure prediction may soon be worthwhile. For the three targets where the human‐assisted predictions were significantly closer to the native structure, we identify the steps that remain to be automated. Proteins 2003;53:457–468.


Proteins | 2005

Free modeling with Rosetta in CASP6

Philip Bradley; Lars Malmström; Bin Qian; Jack Schonbrun; Dylan Chivian; David E. Kim; Jens Meiler; Kira M.S. Misura; David Baker

We describe Rosetta predictions in the Sixth Community‐Wide Experiment on the Critical Assessment of Techniques for Protein Structure Prediction (CASP), focusing on the free modeling category. Methods developed since CASP5 are described, and their application to selected targets is discussed. Highlights include improved performance on larger proteins (100–200 residues) and the prediction of a 70‐residue alpha–beta protein to near‐atomic resolution. Proteins 2005;Suppl 7:128–134.


Proceedings of the National Academy of Sciences of the United States of America | 2007

Prediction of the structure of symmetrical protein assemblies

Ingemar André; Philip Bradley; Chu Wang; David Baker

Biological supramolecular systems are commonly built up by the self-assembly of identical protein subunits to produce symmetrical oligomers with cyclical, icosahedral, or helical symmetry that play roles in processes ranging from allosteric control and molecular transport to motor action. The large size of these systems often makes them difficult to structurally characterize using experimental techniques. We have developed a computational protocol to predict the structure of symmetrical protein assemblies based on the structure of a single subunit. The method carries out simultaneous optimization of backbone, side chain, and rigid-body degrees of freedom, while restricting the search space to symmetrical conformations. Using this protocol, we can reconstruct, starting from the structure of a single subunit, the structure of cyclic oligomers and the icosahedral virus capsid of satellite panicum virus using a rigid backbone approximation. We predict the oligomeric state of EscJ from the type III secretion system both in its proposed cyclical and crystallized helical form. Finally, we show that the method can recapitulate the structure of an amyloid-like fibril formed by the peptide NNQQNY from the yeast prion protein Sup35 starting from the amino acid sequence alone and searching the complete space of backbone, side chain, and rigid-body degrees of freedom.


Proceedings of the National Academy of Sciences of the United States of America | 2008

Emergence of symmetry in homooligomeric biological assemblies

Ingemar André; Charlie E. M. Strauss; David B. Kaplan; Philip Bradley; David Baker

Naturally occurring homooligomeric protein complexes exhibit striking internal symmetry. The evolutionary origins of this symmetry have been the subject of considerable speculation; proposals for the advantages associated with symmetry include greater folding efficiency, reduced aggregation, amenability to allosteric regulation, and greater adaptability. An alternative possibility stems from the idea that to contribute to fitness, and hence be subject to evolutionary optimization, a complex must be significantly populated, which implies that the interaction energy between monomers in the ancestors of modern-day complexes must have been sufficient to at least partially overcome the entropic cost of association. Here, we investigate the effects of this bias toward very-low-energy complexes on the distribution of symmetry in primordial homooligomers modeled as randomly interacting pairs of monomers. We demonstrate quantitatively that a bias toward very-low-energy complexes can result in the emergence of symmetry from random ensembles in which the overall frequency of symmetric complexes is vanishingly small. This result is corroborated by using explicit protein–protein docking calculations to generate ensembles of randomly docked complexes: the fraction of these that are symmetric increases from 0.02% in the overall population to >50% in very low energy subpopulations.


PLOS ONE | 2012

Targeting G with TAL Effectors: A Comparison of Activities of TALENs Constructed with NN and NK Repeat Variable Di-Residues

Michelle Christian; Zachary L. Demorest; Colby G. Starker; Mark J. Osborn; Michael D. Nyquist; Yong Zhang; Daniel F. Carlson; Philip Bradley; Adam J. Bogdanove; Daniel F. Voytas

The DNA binding domain of Transcription Activator-Like (TAL) effectors can easily be engineered to have new DNA sequence specificities. Consequently, engineered TAL effector proteins have become important reagents for manipulating genomes in vivo. DNA binding by TAL effectors is mediated by arrays of 34 amino acid repeats. In each repeat, one of two amino acids (repeat variable di-residues, RVDs) contacts a base in the DNA target. RVDs with specificity for C, T and A have been described; however, among RVDs that target G, the RVD NN also binds A, and NK is rare among naturally occurring TAL effectors. Here we show that TAL effector nucleases (TALENs) made with NK to specify G have less activity than their NN-containing counterparts: fourteen of fifteen TALEN pairs made with NN showed more activity in a yeast recombination assay than otherwise identical TALENs made with NK. Activity was assayed for three of these TALEN pairs in human cells, and the results paralleled the yeast data. The in vivo data is explained by in vitro measurements of binding affinity demonstrating that NK-containing TAL effectors have less affinity for targets with G than their NN-containing counterparts. On targets for which G was substituted with A, higher G-specificity was observed for NK-containing TALENs. TALENs with different N- and C-terminal truncations were also tested on targets that differed in the length of the spacer between the two TALEN binding sites. TALENs with C-termini of either 63 or 231 amino acids after the repeat array cleaved targets across a broad range of spacer lengths – from 14 to 33 bp. TALENs with only 18 aa after the repeat array, however, showed a clear optimum for spacers of 13 to 16 bp. The data presented here provide useful guidelines for increasing the specificity and activity of engineered TAL effector proteins.

Collaboration


Dive into the Philip Bradley's collaboration.

Top Co-Authors

Avatar

David Baker

University of Washington

View shared research outputs
Top Co-Authors

Avatar

David E. Kim

University of Washington

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Chen Yanover

Fred Hutchinson Cancer Research Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Barry L. Stoddard

Fred Hutchinson Cancer Research Center

View shared research outputs
Top Co-Authors

Avatar

Bin Qian

University of Washington

View shared research outputs
Top Co-Authors

Avatar

Chu Wang

Scripps Research Institute

View shared research outputs
Top Co-Authors

Avatar

Dylan Chivian

Lawrence Berkeley National Laboratory

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge